Skip to main content

Market Overview

Recap: NovoCure Q3 Earnings

Recap: NovoCure Q3 Earnings


NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM.

Here's what investors need to know about the announcement.


NovoCure missed their estimated earnings by 85.71%, reporting an EPS of $-0.13 versus an estimate of $-0.07, which surprised analysts.

Revenue was up $946,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15, which was followed by a 6.09% drop in the share price the next day.

Here's a look at NovoCure's past performance:


Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate 0.01 0.02 0.12 0.03
EPS Actual -0.14 -0.04 0.04 0.09
Revenue Estimate 141.89M 139.36M 141.29M 120.24M
Revenue Actual 133.52M 134.69M 143.95M 132.66M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.


Related Articles (NVCR)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at